|
![]() |
Breast Cancer > Placebo
The following information is about Placebo.
Placebo Defined
An inactive substance used in controlled studies of drugs. The placebo is given to one group of patients and the drug being tested is given to a similar group of patients. The results obtained from these two groups are then evaluated and compared.
This definition is in context to Breast Cancer. See more contextual defintions for Placebo.
Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
Published August 28, 2008, 2:23 am, PR Newswire via Yahoo! Finance
-
Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
Published August 28, 2008, 2:22 am, PR Newswire via Yahoo! Finance
Algeta ASA , the Norwegian cancer therapeutics company, today announced that the primary objective of its BC1-03 Phase II pain palliation study was met. The study showed that even single doses of Alpharadin in patients with painful bone metastases could produce increasing clinical benefit with increasing dose.
Juices affect drugs
Published August 28, 2008, 1:40 am, Louisville Courier-Journal
Grapefruit juice, long known to boost the absorption of certain medications, isn't the only juice that doesn't mix well with drugs, according to a Canadian researcher. Other common juices, including orange and apple, may limit the body's absorption of drugs, compromising their effectiveness.
Zealand Pharma today announced that Dr. David H Solomon has been appointed Chief Executive Officer
Published August 27, 2008, 10:00 pm, Marketwire via Yahoo! Finance
Today Zealand Pharma announced that Dr. David H Solomon has been appointed Chief Executive Officer. "We are delighted to have David as the new Chief Executive Officer. He brings more than 20 years of experience in medical research, healthcare investing and key biopharmaceutical and medical device operating roles," said Dr.
Morphotek opens clinical sites in EU for phase II pancreatic cancer drug trial
Published August 27, 2008, 9:43 pm, PharmaBiz
Morphotek, Inc, a subsidiary of Eisai Corporation of North America, announced that it has opened clinical sites in the European Union (EU) as part of the company's MORAb-009 phase-II study.
Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery
Published August 27, 2008, 3:12 pm, News-Medical-Net
Novartis has announced that Gleevec (imatinib mesylate) tablets, (known as Glivec (imatinib) outside the US, Canada and Israel), has been granted priority review status by the US Food and Drug Administration (FDA) as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors (GIST).
Another Storm Brewing For Vytorin
Published August 27, 2008, 2:12 pm, Forbes
Data on whether it causes cancer are set to be released next week.
Efficacy Questions Still Dog Vytorin
Published August 27, 2008, 10:44 am, Forbes
If the Merck/Schering-Plough drug escapes worries about cancer, there is still the question of whether it works.
Curis Announces Nature Publication Elucidating a Paracrine Mechanism of Action in Hedgehog-Expressing Tumors
Published August 27, 2008, 10:29 am, Centre Daily Times
Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing next generation proprietary targeted medicines for cancer treatment, today announced the publication of preclinical data in Nature that support the premise that Hedgehog proteins play an important role in supporting tumor growth in Hedgehog-expressing solid tumors through a paracrine mechanism of action.
Novartis says FDA will give a faster review to Gleevec as gastrointestinal cancer treatment
Published August 27, 2008, 5:17 am, Canadian Business
NEW YORK (AP) - Drug maker Novartis AG said Wednesday that the Food and Drug Administration has granted a priority review to its drug Gleevec as a treatment for intestinal cancer — meaning the agency intends to make a ruling within six months.
Are you looking for additional Breast Cancer > Placebo news? Try our new "Placebo News Focus" area.
Off-site Placebo Links, User Submitted
The following links have been collected through user bookmark submission in the Placebo category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Tue Aug 26
- The power of the placebo effect - being-human - 20 August 2008 - New Scientist
- Believing is seeing: expectations alter visual awareness: Current Biology -- Sterzer et al.
- Placebo - Wikipedia, the free encyclopedia
Mon Aug 25
Sun Aug 24
- EFT Provides Impressive Health and Emotional Freedom--New Discovery Often Works Where Nothing Else: Where emotional relief brings physical health. Is this a giant placebo?
- Mind Hacks: Placebo - interactive ingredients
Sat Aug 23
- Bad Science " My Placebo programme on BBC Radio 4: Placebo Our beliefs and expectations about treatments can have a dramatic effect on our health ? the so-called ?placebo effect?. Doctor and writer Ben Goldacre presents a two part series.
Fri Aug 22
- Bad Science " Think yourself thin...: Maybe mindset alone can influence metabolism and the benefits of exercise: perhaps this experiment shows, essentially, the placebo benefits of exercise.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Placebo. If you would like to find related tags we recommend Tag Patterns > Placebo
Off-site Placebo Research Links
If you still need additional information on Placebo then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Breast Cancer Topics
Everything you need to know about Breast Cancer
Breast Cancer
If you know the Breast Cancer Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Breast-Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.
